THC Global targets product range expansion and entry into Asia Pacific, Latin America markets
Zelira Therapeutics accelerates towards commercialisation in 2020
Admedus encouraged by smooth start to new sales model, including first major manufacturing order
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.